What type of drug is Lumify?

Boost your readiness for the Primary Open-Angle Glaucoma Test. Utilize flashcards and multiple-choice questions complete with hints and detailed explanations to enhance your understanding.

Multiple Choice

What type of drug is Lumify?

Explanation:
Lumify is brimonidine tartrate ophthalmic solution, a selective alpha-2 adrenergic agonist. ItRelieves redness by activating alpha-2 receptors on the superficial conjunctival vessels, causing vasoconstriction and reduced blood flow, so the visible redness diminishes. It’s not a prostaglandin analogue (which alter outflow to lower IOP), not a beta-blocker (also typically lowering IOP via reduced aqueous production), and not a cholinergic agonist (which would cause pupil constriction and ciliary muscle effects). The mechanism and用途 align with alpha-2 receptor activation for rapid redness relief.

Lumify is brimonidine tartrate ophthalmic solution, a selective alpha-2 adrenergic agonist. ItRelieves redness by activating alpha-2 receptors on the superficial conjunctival vessels, causing vasoconstriction and reduced blood flow, so the visible redness diminishes. It’s not a prostaglandin analogue (which alter outflow to lower IOP), not a beta-blocker (also typically lowering IOP via reduced aqueous production), and not a cholinergic agonist (which would cause pupil constriction and ciliary muscle effects). The mechanism and用途 align with alpha-2 receptor activation for rapid redness relief.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy